CSI Market
Sign In | Register

Engene Therapeutics Inc (ENGN) Annual Balance Sheets

Annual · GAAP · USD millions
Access ENGN quarterly Balance Sheets →
This page allows investors to track Engene Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ENGN/balance-sheets
https://api.csimarket.com/api/v1/companies/ENGN/fundamentals
https://api.csimarket.com/api/v1/companies/ENGN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Oct 31 2025)
(Oct 31 2024) (Oct 31 2023)
Assets
Cash & cash equivalent50.15
Marketable Securities, Current SH143.58
Cash & Short-term Investments193.00
Other Current Assets1.01
Prepaid Expense And Other Assets Current6.65
Total Current Assets201.39
Equipment/Property/Plant Net2.48
Long-term investments8.52
Other Assets, Noncurrent10.00
Investment Tax Credits Receivable-
Investment Tax Credits Receivable-
Investment Tax Credits Receivable0.93
Total Assets221.47
Liabilities
Accounts Payable, Current AC6.69
Accrued Liabilities And Other Liabilities15.28
Notes Payable, Current NO8.00
Total Current Liabilities31.98
Long-term debt15.32
Total Long-term Debt15.32
Other liabilities, Noncurrent6.46
Operating Lease Liability Current2.01
Total Liabilities53.76
Stockholders' Equity
Common Stock Value513.28
Additional Paid In Capital Common Stock27.35
Retained Earnings / Accumulated Deficit-372.03
Other Equity-0.89
Common Stockholder's Equity167.71
Total Stockholder's Equity167.71
Liabilities & Stockholder's Equity221.47
4 historic quarters locked

Sign in to unlock the full Engene Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Engene Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251031)
  • Filed with the SEC: December 22, 2025
  • Source: engn-20251031.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-25-328743

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI